ANGIODYNAMICS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AngioDynamics, Inc. on May 10, 2006. The report discloses corporate governance actions taken by the Board of Directors on that date, specifically regarding director and officer indemnification and amendments to the Code of Business Conduct and Ethics.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on legal and governance matters rather than financial performance.
Material Changes
There are no material financial changes reported. The significant events disclosed are:
- Indemnification Agreement: The Board reapproved the standard indemnification agreement for directors and officers. The Company entered into this agreement with each director and officer, providing indemnification to the fullest extent permitted by law against expenses, judgments, fines, and settlements. The Company will also advance expense amounts upon request.
- Code of Ethics Amendments: The Board approved amendments to the Code of Business Conduct and Ethics. Key changes include:
- Mandatory reporting of existing or potential violations with clarified contact persons.
- Deletion of the requirement for Board approval of all conflicts of interest for practical reasons.
- Requirement that gifts and business gratuities comply with the Compliance Plan and IRS regulations.
- Requirement for prior approval by an Appropriate Ethics Contact for waivers of any Code provision (waivers for executives and directors remain subject to Board approval).
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies are detailed beyond the standard legal protections outlined in the indemnification agreement.
Key Facts for Investor Verification
- Verify the full text of the Indemnification Agreement (Exhibit 10.1) to understand specific limitations and obligations.
- Review the amended Code of Business Conduct and Ethics (Exhibit 14) to assess changes in compliance and conflict of interest protocols.
- Confirm that the amended Code has been posted on the Company's Investor-Corporate Governance website as stated.